Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

In tests with volunteers, the device successfully captured color images of the retina, showing features such as the optic disc, blood vessels, and macula. Importantly, the images could be refocused ...

Avoiding and managing ocular radiotoxicity are increasingly important as more patients undergo radiotherapy for HNC, esp.

Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change ...

Semaglutide treatment was not associated with an increased risk for eye disorders or diabetic retinopathy but may increase NAION risk.

A new study reveals that levels of the SLIT2 protein in eye and blood samples are linked to cognitive performance in ...

Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change ...

Significant gaps exist in HCPs' knowledge, attitudes, and practices regarding DR screening, particularly among non-ophthalmic professionals. Inadequate training, lack of screening tools, and high ...

MONDAY, Aug. 18, 2025 (HealthDay News) -- For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review ...

Boehringer Ingelheim has inked a deal with Palatin Technologies worth up to €280 million (about $327 million) biobucks with the aim of developing new retinal disease therapies. The German drugmaker ...

China’s leading artificial intelligence startup DeepSeek Ltd., which took the industry by storm earlier this year, was reportedly forced to delay the release of its upcoming R2 model after struggling ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...